SynthesisThe Cochrane database of systematic reviews2012

Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory or resistant metastatic breast cancer.

Anna Dorothea Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.